Copyright
©2014 Baishideng Publishing Group Inc.
World J Nephrol. Aug 6, 2014; 3(3): 92-100
Published online Aug 6, 2014. doi: 10.5527/wjn.v3.i3.92
Published online Aug 6, 2014. doi: 10.5527/wjn.v3.i3.92
Table 3 Previous diagnosis of cancer in patients undergoing endoscopic ultrasound guided fine-needle aspiration
Previous diagnosis ofcancer (n = 40) | Benign cytology on EUS-FNA(n = 21) | Malignant cytology on EUS-FNA(n = 15) | Non-diagnostic cytology onEUS-FNA(n = 4) |
Penile cancer | 0 | 1 | 0 |
Oral SCC | 0 | 1 | 0 |
Lung cancer | 15 | 3 | 1 |
Renal cell carcinoma | 0 | 2 | 1 |
Esophageal ADC | 1 | 3 | 0 |
Breast cancer | 1 | 1 | 0 |
Gastric ADC | 1 | 1 | 0 |
Hepatocellular carcinoma | 0 | 1 | 0 |
Pulmonary carcinoid | 0 | 0 | 1 |
Colon ADC | 0 | 1 | 1 |
SCC of the duodenum | 1 | 0 | 0 |
Basal cell cancer of the skin | 1 | 0 | 0 |
Bladder cancer | 1 | 0 | 0 |
Melanoma | 0 | 1 | 0 |
- Citation: Martinez M, LeBlanc J, Al-Haddad M, Sherman S, DeWitt J. Role of endoscopic ultrasound fine-needle aspiration evaluating adrenal gland enlargement or mass. World J Nephrol 2014; 3(3): 92-100
- URL: https://www.wjgnet.com/2220-6124/full/v3/i3/92.htm
- DOI: https://dx.doi.org/10.5527/wjn.v3.i3.92